14 PSA based intermediate endpoints to compare cancer specific survival difference between radiotherapy and radical prostatectomy for the treatment of localized prostate cancer
Saved in:
Main Authors: | P. Wiklund, U. Falagario, F. Pellegrino, A. Lantz, O. Akre |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168325000175 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radical Prostatectomy: An Option for High-Risk Prostate Cancer
by: S. Rausch, et al.
Published: (2012-01-01) -
The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01) -
The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
by: Carolin Siech, et al.
Published: (2025-02-01) -
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
by: M. Kamrava, et al.
Published: (2009-01-01) -
Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
by: Mats Steinholtz Ahlberg, et al.
Published: (2022-12-01)